학술논문

Results of an Open Label, Dose Escalating, Phase 1 Clinical Trial Evaluating the Safety of a Human Neural Stem Cell Based Therapy in Parkinson's Disease
Document Type
Journal
Source
NEUROLOGY; APR 9 2019, 92 15, 3p. Supplement: S
Subject
Language
English
ISSN
1526632X